Verified earnings results
Scribe Therapeutics Q3 2026 Earnings Results
Direct answer
Scribe Therapeutics reported Q3 2026 results on November 12, 2026.
Revenue was 1,636,000. EPS beat the estimate by 21.94%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Scribe Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 12, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.8711
- Reported EPS
- -0.68
- Revenue
- 1,636,000
- EPS surprise
- EPS beat the estimate by 21.94%.
Explore related company data
Read the frequently asked questions.
When did Scribe Therapeutics report Q3 2026 earnings?
Scribe Therapeutics reported on November 12, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Scribe Therapeutics?
The verified record provides an EPS estimate of -0.8711.
Has Scribe Therapeutics reported the Q3 2026 result?
Revenue was 1,636,000. EPS beat the estimate by 21.94%.
Which source supports this Scribe Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.